Blockchain Registration Transaction Record

Silo Pharma's QwikAgents Joins AMD AI Developer Program

Silo Pharma's subsidiary QwikAgents joins AMD AI Developer Program to accelerate AI agent platform development with AMD Cloud credits and tools.

This news matters because it signals Silo Pharma's strategic expansion into artificial intelligence, diversifying beyond its core biopharmaceutical focus. By joining the AMD AI Developer Program, QwikAgents gains access to cutting-edge tools and resources that could significantly accelerate the development of its AI agent platform. For investors, this move may open new growth avenues and potentially enhance the company's valuation. For the tech community, it represents another example of AI integration in business operations, showcasing how even biopharma companies are leveraging AI to create value.